Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Isradipine in Parkinson's Disease
NCT00753636Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Apr 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Isradipine in Parkinson's disease (PD), sponsored by Northwestern University. Started Apr 2008; status: completed.
02
Drugs
Isradipine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00753636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753636.